Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Gerard Silvestri and Nichole Tanner.
Gerard Silvestri
Connection Strength
19.554
Nichole Tanner
  1. Response. Chest. 2021 05; 159(5):2122.
    View in: PubMed
    Score: 0.751
  2. Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2021 03; 159(3):1283-1287.
    View in: PubMed
    Score: 0.727
  3. Association of Cigarette Type and Nicotine Dependence in Patients Presenting for Lung Cancer Screening. Chest. 2020 11; 158(5):2184-2191.
    View in: PubMed
    Score: 0.709
  4. Screening Adherence in the Veterans Administration Lung Cancer Screening Demonstration Project. Chest. 2020 10; 158(4):1742-1752.
    View in: PubMed
    Score: 0.704
  5. Association of Cigarette Type With Lung Cancer Incidence and Mortality: Secondary Analysis of the National Lung Screening Trial. JAMA Intern Med. 2019 12 01; 179(12):1710-1712.
    View in: PubMed
    Score: 0.681
  6. Effect of a Rule-in Biomarker Test on Pulmonary Nodule Management: A Survey of Pulmonologists and Thoracic Surgeons. Clin Lung Cancer. 2020 03; 21(2):e89-e98.
    View in: PubMed
    Score: 0.659
  7. In-person and Telephonic Shared Decision-making Visits for People Considering Lung Cancer Screening: An Assessment of Decision Quality. Chest. 2019 01; 155(1):236-238.
    View in: PubMed
    Score: 0.639
  8. Shared Decision-making and Lung Cancer Screening: Let's Get the Conversation Started. Chest. 2019 01; 155(1):21-24.
    View in: PubMed
    Score: 0.631
  9. Standard Bronchoscopy With Fluoroscopy vs Thin Bronchoscopy and Radial Endobronchial Ultrasound for Biopsy of Pulmonary Lesions: A Multicenter, Prospective, Randomized Trial. Chest. 2018 11; 154(5):1035-1043.
    View in: PubMed
    Score: 0.624
  10. Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease. Am J Respir Crit Care Med. 2017 09 01; 196(5):602-608.
    View in: PubMed
    Score: 0.583
  11. Response. Chest. 2017 08; 152(2):448-449.
    View in: PubMed
    Score: 0.579
  12. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest. 2017 08; 152(2):263-270.
    View in: PubMed
    Score: 0.559
  13. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016 Mar 01; 193(5):534-41.
    View in: PubMed
    Score: 0.525
  14. Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest. 2015 Dec; 148(6):1405-1414.
    View in: PubMed
    Score: 0.516
  15. POINT: Is N2 Disease a Contraindication for Surgical Resection for Superior Sulcus Tumors? Yes. Chest. 2015 Dec; 148(6):1373-1375.
    View in: PubMed
    Score: 0.516
  16. What's in a Number? When It Comes to Pulmonary Nodules, It's All About the Number. Am J Respir Crit Care Med. 2015 Nov 15; 192(10):1149-50.
    View in: PubMed
    Score: 0.515
  17. Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation. Am J Respir Crit Care Med. 2015 Jul 15; 192(2):200-8.
    View in: PubMed
    Score: 0.503
  18. Screening for Lung Cancer Using Low-Dose Computed Tomography. Are We Headed for DANTE's Paradise or Inferno? Am J Respir Crit Care Med. 2015 May 15; 191(10):1100-1.
    View in: PubMed
    Score: 0.497
  19. Attitudes and beliefs toward lung cancer screening among US Veterans. Chest. 2013 Dec; 144(6):1783-1787.
    View in: PubMed
    Score: 0.449
  20. Simultaneously diagnosing and staging lung cancer: a win-win for the patient and the health-care system. Chest. 2013 Dec; 144(6):1747-1749.
    View in: PubMed
    Score: 0.449
  21. Training for linear endobronchial ultrasound among US pulmonary/critical care fellowships: a survey of fellowship directors. Chest. 2013 Feb 01; 143(2):423-428.
    View in: PubMed
    Score: 0.424
  22. Lung cancer screening with low-dose CT: benefits and potential risks. Evid Based Med. 2013 Jun; 18(3):108-9.
    View in: PubMed
    Score: 0.416
  23. Biomarkers in the selection of maintenance therapy in non-small cell lung cancer. Transl Lung Cancer Res. 2012 Jun; 1(2):96-8.
    View in: PubMed
    Score: 0.405
  24. Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection. J Thorac Oncol. 2012 Feb; 7(2):365-9.
    View in: PubMed
    Score: 0.396
  25. New testing for lung cancer screening. Oncology (Williston Park). 2012 Feb; 26(2):176-82.
    View in: PubMed
    Score: 0.396
  26. The role of molecular analyses in the era of personalized therapy for advanced NSCLC. Lung Cancer. 2012 May; 76(2):131-7.
    View in: PubMed
    Score: 0.392
  27. Utilizing endobronchial ultrasound with fine-needle aspiration to obtain tissue for molecular analysis: a single-center experience. J Bronchology Interv Pulmonol. 2011 Oct; 18(4):317-21.
    View in: PubMed
    Score: 0.387
  28. An up to date look at lung cancer screening. Cell Adh Migr. 2010 Jan-Mar; 4(1):96-9.
    View in: PubMed
    Score: 0.344
  29. Denture misadventure: an unusual cause of hemoptysis. J Bronchology Interv Pulmonol. 2009 Jul; 16(3):216-8.
    View in: PubMed
    Score: 0.331
  30. Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging. Chest. 2023 Feb 10.
    View in: PubMed
    Score: 0.213
  31. Guided Bronchoscopy for the Evaluation of Pulmonary Lesions: An Updated Meta-analysis. Chest. 2023 Jan 11.
    View in: PubMed
    Score: 0.211
  32. Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study. Ann Intern Med. 2022 Nov; 175(11):1501-1505.
    View in: PubMed
    Score: 0.208
  33. Factors Associated With Smoking Cessation Attempts in Lung Cancer Screening: A Secondary Analysis of the National Lung Screening Trial. Chest. 2023 02; 163(2):433-443.
    View in: PubMed
    Score: 0.207
  34. Response. Chest. 2021 01; 159(1):438-439.
    View in: PubMed
    Score: 0.184
  35. Occurrence of Discussion about Lung Cancer Screening Between Patients and Healthcare Providers in the USA, 2017. J Cancer Educ. 2020 08; 35(4):678-681.
    View in: PubMed
    Score: 0.178
  36. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. J Am Coll Radiol. 2020 Jul; 17(7):845-854.
    View in: PubMed
    Score: 0.175
  37. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Radiol Imaging Cancer. 2020 05; 2(3):e204013.
    View in: PubMed
    Score: 0.175
  38. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Chest. 2020 07; 158(1):406-415.
    View in: PubMed
    Score: 0.175
  39. An Evaluation of Diagnostic Yield From Bronchoscopy: The Impact of Clinical/Radiographic Factors, Procedure Type, and Degree of Suspicion for Cancer. Chest. 2020 06; 157(6):1656-1664.
    View in: PubMed
    Score: 0.172
  40. Reviewing Lung Cancer Screening: The Who, Where, When, Why, and How. Clin Chest Med. 2018 03; 39(1):31-43.
    View in: PubMed
    Score: 0.151
  41. Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2018 09; 154(3):491-500.
    View in: PubMed
    Score: 0.151
  42. Comparing Pulmonary Nodule Location During Electromagnetic Bronchoscopy With Predicted Location on the Basis of Two Virtual Airway Maps at Different Phases of?Respiration. Chest. 2018 01; 153(1):181-186.
    View in: PubMed
    Score: 0.144
  43. Viewing All the Trees in the Forest: The Importance of Reporting Abnormal Findings on CT Scan When Screening for Lung Cancer. Chest. 2017 03; 151(3):525-526.
    View in: PubMed
    Score: 0.141
  44. Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study. Ann Am Thorac Soc. 2016 11; 13(11):1977-1982.
    View in: PubMed
    Score: 0.138
  45. Rebuttal From Drs Tanner and Silvestri. Chest. 2015 Dec; 148(6):1379-1380.
    View in: PubMed
    Score: 0.129
  46. Reply: Lung Cancer Screening: The Balance between Harm and Benefit. Am J Respir Crit Care Med. 2015 May 15; 191(10):1209-10.
    View in: PubMed
    Score: 0.124
  47. Screening and early detection efforts in lung cancer. Cancer. 2015 May 01; 121(9):1347-56.
    View in: PubMed
    Score: 0.121
  48. Lung cancer screening. Am J Respir Crit Care Med. 2015 Jan 01; 191(1):19-33.
    View in: PubMed
    Score: 0.121
  49. Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Chest. 2014 Aug; 146(2):406-411.
    View in: PubMed
    Score: 0.118
  50. Response. Chest. 2014 Aug; 146(2):e70.
    View in: PubMed
    Score: 0.118
  51. The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest. 2014 Mar 01; 145(3):464-472.
    View in: PubMed
    Score: 0.114
  52. Diagnostic approach to the solitary pulmonary nodule. Semin Respir Crit Care Med. 2013 Dec; 34(6):762-9.
    View in: PubMed
    Score: 0.112
  53. Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest. 2011 Dec; 140(6):1550-1556.
    View in: PubMed
    Score: 0.094
  54. A 79-year-old woman with a right paratracheal mass. Chest. 2009 May; 135(5):1384-1388.
    View in: PubMed
    Score: 0.082
  55. Tobacco Treatment Specialist Training for Lung Cancer Screening Providers. Am J Prev Med. 2021 11; 61(5):765-768.
    View in: PubMed
    Score: 0.048
  56. Safely and Effectively Evaluating Computed Tomography-detected Lung Lesions. Much Work to Be Done. Ann Am Thorac Soc. 2019 11; 16(11):1360-1362.
    View in: PubMed
    Score: 0.042
  57. Impact of Tobacco Dependence in Risk Prediction Models for Lung Cancer Diagnoses and Deaths. JNCI Cancer Spectr. 2019 Jun; 3(2):pkz014.
    View in: PubMed
    Score: 0.041
  58. Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for?Moderate Sedation During Bronchoscopy. Chest. 2019 01; 155(1):137-146.
    View in: PubMed
    Score: 0.039
  59. Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2018 07 15; 198(2):e3-e13.
    View in: PubMed
    Score: 0.039
  60. Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial. Chest. 2018 07; 154(1):110-118.
    View in: PubMed
    Score: 0.038
  61. Underuse of Chest Radiography Versus Computed Tomography for Lung Cancer Screening. Am J Public Health. 2017 08; 107(8):1248-1250.
    View in: PubMed
    Score: 0.036
  62. Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival. Chest. 2017 09; 152(3):587-597.
    View in: PubMed
    Score: 0.036
  63. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. Ann Am Thorac Soc. 2016 09; 13(9):1568-74.
    View in: PubMed
    Score: 0.034
  64. Factors that influence physician decision making for indeterminate pulmonary nodules. Ann Am Thorac Soc. 2014 Dec; 11(10):1586-91.
    View in: PubMed
    Score: 0.030
  65. Construct validity of the Simbionix bronch mentor simulator for essential bronchoscopic skills. J Bronchology Interv Pulmonol. 2014 Oct; 21(4):314-21.
    View in: PubMed
    Score: 0.030
  66. Outcome of patients with negative and unsatisfactory cytologic specimens obtained by endobronchial ultrasound-guided transbronchial fine-needle aspiration of mediastinal lymph nodes. Cancer Cytopathol. 2015 Feb; 123(2):92-7.
    View in: PubMed
    Score: 0.030
  67. The latest generation in flexible bronchoscopes: a description and evaluation. J Bronchology Interv Pulmonol. 2013 Oct; 20(4):357-62.
    View in: PubMed
    Score: 0.028
  68. Lung cancer: progress in diagnosis, staging and therapy. Respirology. 2010 Jan; 15(1):44-50.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.